These innovative therapies , Retatrutide, represent a groundbreaking advancement in managing obesity and conceivably related conditions . They are grouped as GLP-1 receptor activators , meaning they function to mimic the body's GLP-1 peptide, enhancing metabolic release and reducing appetite . While Semaglutide each one operates somewhat similarly,